Oxygen therapy shows promise in brain cancer fight
NCT ID NCT03862430
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 32 times
Summary
This study tests whether adding an experimental drug called NanO2 to standard radiation and chemotherapy can help people with newly diagnosed glioblastoma, an aggressive brain cancer. NanO2 is designed to deliver more oxygen to tumors, which may make radiation work better. About 87 adults will take part, and researchers will track how long the cancer stays under control and overall survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Atlantic Health System
Summit, New Jersey, 07901, United States
-
Center for Neurosciences
Tucson, Arizona, 85718, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Inova Schar Cancer Institute
Fairfax, Virginia, 22031, United States
-
Ochsner Clinic Foundation
New Orleans, Louisiana, 70121, United States
-
Providence St. John's Cancer Institute
Santa Monica, California, 90404, United States
-
Saint Luke's Cancer Institute
Kansas City, Missouri, 64111, United States
-
St. Francis Medical Center, OSF Healthcare
Peoria, Illinois, 61637, United States
-
UC Irvine Health- Chao Family Comprehensive Cancer Center
Orange, California, 92868, United States
-
University Hospitals Seidman Cancer Center
Cleveland, Ohio, 44106, United States
-
University of Arizona
Tucson, Arizona, 85719, United States
-
Yale Cancer Center
New Haven, Connecticut, 06520, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.